AUBADE

AUBADE project provides an innovative tool that will lead professionals to a deep study, analysis, understanding, and comprehension of neurological diseases and human emotions.

AUBADE project has developed an intelligent, multisensor and wearable system for the assessment of the emotional state of humans under special conditions. The project has involved the utilization of innovative technologies such as the recognition of the emotions after the processing of the following biomedical signals: EMG, obtained from the face of the users, ECG, skin conductivity and respiration rate.

AUBADE results in a modular and multifunctional system to be applicable in different areas. Initially it is being be utilized in the health sector, primarily in the neurology and psychology areas, and also in the car racing sector.

AUBADE objective is the implementation of an intelligent, multisensorial wearable system that can ubiquitously monitor and classify the emotional state of users in near time using signals mainly obtained from their faces.

AUBADE platform incorporates a wearable system that obtains signals from multiple appropriate biosensors mainly placed on the face of the user (EMG, ECG, skin conductivity and respiration rate). The system is being used in a variety of healthcare applications mainly in the neurology and psychology field. Additionally, there are other areas of application, as the racing car sector.

AUBADE has been designed to be highly modular and can be easily adapted or break-up in stand alone modules, in order to accommodate a wide variety of neurological and psychological conditions.

For further information, please visit:
http://www.aubade-group.com

Project co-ordinator:
SIEMENS, S.A.

Partners:

  • SIEMENS, S.A. (ES)
  • AZIENDA UNITA SANITARIA LOCALE DI MODENA (IT)
  • ANCO S.A. Agencies, Commerce & Industry (GR)
  • University of Ioannina (GR)
  • MASERATI S.P.A. (IT)

Timetable: from 01/04 - to 07/06

Total cost: € 3.567.434,98

EC funding: € 2.000.000

Instrument: STREP

Project Identifier: IST-2002-507605

Most Popular Now

Research Shows AI Technology Improves Pa…

Existing research indicates that the accuracy of a Parkinson's disease diagnosis hovers between 55% and 78% in the first five years of assessment. That's partly because Parkinson's sibling movement disorders...

Who's to Blame When AI Makes a Medi…

Assistive artificial intelligence technologies hold significant promise for transforming health care by aiding physicians in diagnosing, managing, and treating patients. However, the current trend of assistive AI implementation could actually...

First Therapy Chatbot Trial Shows AI can…

Dartmouth researchers conducted the first clinical trial of a therapy chatbot powered by generative AI and found that the software resulted in significant improvements in participants' symptoms, according to results...

DMEA sparks: The Future of Digital Healt…

8 - 10 April 2025, Berlin, Germany. Digitalization is considered one of the key strategies for addressing the shortage of skilled workers - but the digital health sector also needs qualified...

DeepSeek: The "Watson" to Doct…

DeepSeek is an artificial intelligence (AI) platform built on deep learning and natural language processing (NLP) technologies. Its core products include the DeepSeek-R1 and DeepSeek-V3 models. Leveraging an efficient Mixture...

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...